The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
immune globulin (human) · Injection, Solution
7 marketed package NDCs · 1 active manufacturer
Most dispensed: HUMAN IMMUNOGLOBULIN G 10 g/100mL · Injection · #1 vial, glass/carton / 200 ml in 1 vial, glass
Same drug class
Other molecules FDA puts in Human Immunoglobulin G, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- human botulinum neurotoxin a/b immune globulin· 1 maker
- human cytomegalovirus immune globulin· 1 maker
- immune globulin infusion (human)· 1 maker
- immune globulin intravenous (human) 10%· 1 maker
- immune globulin subcutaneous (human)· 1 maker
- immune globulin subcutaneous, human-klhw· 1 maker
- rho(d) immune globulin (human)· 1 maker
- vaccinia immune globulin intravenous (human)· 1 maker
- immune globulin· 2 makers
- immune globulin intravenous, human - dira· 2 makers
- immunoglobulin g· 2 makers
- human rho(d) immune globulin· 3 makers
Common questions
- Is Immune globulin (human) in shortage right now?
- No. FDA does not currently list Immune globulin (human) in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Immune globulin (human)?
- 2 companies have marketed Immune globulin (human) in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.